Standardized Concentrations Needed For Pediatric Cough/Cold Safety – CDER
This article was originally published in The Tan Sheet
Executive Summary
Standardizing the concentrations of ingredients in OTC cough/cold products would help reduce confusion between formulations for children and those for infants, FDA's Center for Drug Evaluation and Research recommends
You may also be interested in...
Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.